For each method, we built multivariate Cox regression models from the pseudobulk GE to predict survival for three subtypes of breast cancer (BC): HER2+ BC, triple-negative breast cancer (TNBC) and luminal BC. This evidence concerns the gene ERBB2 and breast carcinoma.